IR@PKUHSC  > 北京大学医药卫生分析中心
学科主题公共卫生
Evaluation of In-111-Labeled Cyclic RGD Peptides: Tetrameric not Tetravalent
Chakraborty, Sudipta1; Shi, Jiyun1,2; Kim, Young-Seung1; Zhou, Yang1; Jia, Bing2; Wang, Fan2; Liu, Shuang1
刊名BIOCONJUGATE CHEMISTRY
2010-05-01
DOI10.1021/bc900555q
21期:5页:969-978
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemical Research Methods ; Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary ; Chemistry, Organic
资助者Purdue University ; National Cancer Institute (NCI) ; National Heart, Lung, and Blood Institute (NHLBI) ; Department of Energy ; Purdue University ; National Cancer Institute (NCI) ; National Heart, Lung, and Blood Institute (NHLBI) ; Department of Energy
研究领域[WOS]Biochemistry & Molecular Biology ; Chemistry
关键词[WOS]INTEGRIN ALPHA(V)BETA(3) EXPRESSION ; GLIOMA INTEGRIN-ALPHA(V)BETA(3) EXPRESSION ; RECEPTOR ANTAGONIST USEFUL ; IMPROVING TUMOR UPTAKE ; BIODISTRIBUTION CHARACTERISTICS ; DRUG DEVELOPMENT ; PEG(4) LINKERS ; BREAST-CANCER ; ANGIOGENESIS ; MICROPET
英文摘要

This report presents the synthesis and evaluation of In-111(DOTA-6G-RGD(4)) (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid; 6G-RGD(4) = E{G(3)-E[G(3)-c(RGDfK)](2)}(2) and G(3) = Gly-Gly-Gly), In-111(DOTA-RGD(4)) (RGD(4) = E{E[c(RGDfK)](2)}(2)) and In-111(DOTA-3G-RGD(2)) (3G-RGD(2) = G(3)-E[G(3)-c(RGDfK)](2)) as new radiotracers for imaging integrin alpha(v)beta(3)-positive tumors. The IC50 values of DOTA-6G-RGD(4), DOTA-RGD(4), and DOTA-3G-RGD(2) were determined to be 0.4 +/- 0.1, 1.4 +/- 0.1 and 1.1 +/- 0.1 nM against I-125-c(RGDyK) bound to integrin alpha(v)beta(3)-positive U87MG human glioma cells. In-111(DOTA-6G-RGD(4)), (111)(DOTA-RGD(4)), and In-111(DOTA-3G-RGD(2)) were prepared by reacting (InCl3)-In-111 with the respective DOTA conjugate in NH4OAc buffer (100 mM, pH = 5.5). Radiolabeling could be completed by heating the reaction mixture at 100 degrees C for 15-20 min. The specific activity was similar to 1850 MBq/mu mol for In-111(DOTA-3G-RGD(2)) and similar to 1480 MBq/mu mol for In-111(DOTA-6G-RGD(4)). The athymic nude mice bearing U87MG human glioma xenografts were used to evaluate tumor uptake and excretion kinetics of In-111(DOTA-6G-RGD(4)), In-111(DOTA-RGD(4)), and In-111(DOTA-3G-RGD(2)). The results from both the integrin alpha(v)beta(3) binding assay and biodistribution studies suggest that the tetrameric cyclic ROD peptides, such as RGD(4) and 6G-RGD(4), are most likely bivalent in binding to the integrin alpha(v)beta(3). Both In-111(DOTA-6G-RGD(4)) and In-111(DOTA-RGD(4)) had significantly higher tumor uptake than In-111(DOTA-3G-RGD(2)) at 24-72 h post injection due to the extra RGD motifs in RGD(4) and 60-RGD(4). In-111(DOTA-3G-RGD(2)) had very little metabolism. while In-111(DOTA-6G-RGD(4)) had significant metabolism during its excretion via both renal and hepatobiliary routes over the 2 h period, probably due to its much larger size. The combination of high tumor uptake with long tumor retention suggests that their corresponding Y-90 and Lu-177 analogues M(DOTA-6G-RGD(4)) (M = Y-90 and Lu-177) might be useful as therapeutic radiotracers for treatment of integrin alpha(v)beta(3)-positive solid tumors.

语种英语
所属项目编号R01 CA115883-A2 ; R21 HL08396-01 ; DE-FG02-08ER64684
资助者Purdue University ; National Cancer Institute (NCI) ; National Heart, Lung, and Blood Institute (NHLBI) ; Department of Energy ; Purdue University ; National Cancer Institute (NCI) ; National Heart, Lung, and Blood Institute (NHLBI) ; Department of Energy
WOS记录号WOS:000277683300023
Citation statistics
Cited Times:34[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58906
Collection北京大学医药卫生分析中心
作者单位1.Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
2.Peking Univ, Med Isotopes Res Ctr, Beijing 100191, Peoples R China
Recommended Citation
GB/T 7714
Chakraborty, Sudipta,Shi, Jiyun,Kim, Young-Seung,et al. Evaluation of In-111-Labeled Cyclic RGD Peptides: Tetrameric not Tetravalent[J]. BIOCONJUGATE CHEMISTRY,2010,21(5):969-978.
APA Chakraborty, Sudipta.,Shi, Jiyun.,Kim, Young-Seung.,Zhou, Yang.,Jia, Bing.,...&Liu, Shuang.(2010).Evaluation of In-111-Labeled Cyclic RGD Peptides: Tetrameric not Tetravalent.BIOCONJUGATE CHEMISTRY,21(5),969-978.
MLA Chakraborty, Sudipta,et al."Evaluation of In-111-Labeled Cyclic RGD Peptides: Tetrameric not Tetravalent".BIOCONJUGATE CHEMISTRY 21.5(2010):969-978.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Chakraborty, Sudipta]'s Articles
[Shi, Jiyun]'s Articles
[Kim, Young-Seung]'s Articles
百度学术
百度学术Similar articles in
[Chakraborty, Sudipta]'s Articles
[Shi, Jiyun]'s Articles
[Kim, Young-Seung]'s Articles
必应学术
必应学术Similar articles in
[Chakraborty, Sudipta]'s Articles
[Shi, Jiyun]'s Articles
[Kim, Young-Seung]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.